Mutation detection by pyrosequencing:: sequencing of exons 5-8 of the p53 tumor suppressor gene

被引:65
作者
Garcia, CA [1 ]
Ahmadian, A [1 ]
Gharizadeh, B [1 ]
Lundeberg, J [1 ]
Ronaghi, M [1 ]
Nyrén, P [1 ]
机构
[1] KTH, Royal Inst Technol, Dept Biotechnol, SE-10044 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
bioluminometric assay; cancer; DNA sequencing; multiplex PCR;
D O I
10.1016/S0378-1119(00)00257-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The ability to sequence a large number of DNA samples rapidly and accurately for detection of all possible mutations is a critical goal for the future application of DNA sequencing in routine medical diagnostics. Pyrosequencing(TM) is a non-electrophoretic real-time DNA sequencing method that uses the luciferase-luciferin light release as the detection signal for nucleotide incorporation into target DNA. For pyrosequencing of the human p53 gene, a nested multiplex PCR method for amplification of exons 5-8 was prepared. In order to investigate the use of pyrosequencing in mutation detection, DNA samples from skin-cancer patients were used. Two forms of nucleotide dispensation strategy were used, cyclic and programmed. Bi-directional pyrosequencing was performed and the overlapping sequence data produced were assembled to determine the sequence of the gene. Reliable sequencing data were obtained with both dispensation strategies, but some advantages were obtained using the programmed nucleotide dispensation approach, such as longer and faster reads, and fewer out-of-phase problems. The accuracy of pyrosequencing for detection of p53 mutations and allele distribution was demonstrated. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 29 条
[1]   Analysis of the p53 tumor suppressor gene by pyrosequencing [J].
Ahmadian, A ;
Lundeberg, J ;
Nyrén, P ;
Uhlén, M ;
Ronaghi, M .
BIOTECHNIQUES, 2000, 28 (01) :140-+
[2]   Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array [J].
Ahrendt, SA ;
Halachmi, S ;
Chow, JT ;
Wu, L ;
Halachmi, N ;
Yang, SC ;
Wehage, S ;
Jen, J ;
Sidransky, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7382-7387
[3]  
BERG C, 1995, CLIN CHEM, V41, P1461
[4]   Infrared MALDI mass spectrometry of large nucleic acids [J].
Berkenkamp, S ;
Kirpekar, F ;
Hillenkamp, F .
SCIENCE, 1998, 281 (5374) :260-262
[5]  
Caron De Fromentel Claude, 1992, Genes Chromosomes and Cancer, V4, P1
[6]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[7]  
FEINSTEIN E, 1992, ONCOGENE, V7, P1853
[8]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[9]   WILD-TYPE P53 CAN DOWN-MODULATE THE ACTIVITY OF VARIOUS PROMOTERS [J].
GINSBERG, D ;
MECHTA, F ;
YANIV, M ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :9979-9983
[10]   Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects [J].
Hainaut, P ;
Soussi, T ;
Shomer, B ;
Hollstein, M ;
Greenblatt, M ;
Hovig, E ;
Harris, CC ;
Montesano, R .
NUCLEIC ACIDS RESEARCH, 1997, 25 (01) :151-157